Baldicantos, Baby Boy .

HRN: 24-25-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2023
AMPICILLIN 250MG (VIAL)
12/23/2023
12/29/2023
IV
150mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness 
12/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/23/2023
12/29/2023
IV
45mg
OD
Potentially Septic Newborn
Checking Final Appropriateness 
12/23/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
12/23/2023
12/23/2023
APPLY ON EYE
Apply On Both Eyes
Once
Ophthalmia Neonatorum
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: